Skip to content

Validation of Instruments Used for Assessment of Dysphagia in Patients With Esophageal Cancer

Validation of Instruments Used for Assessment of Dysphagia in Patients With Esophageal Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03066167
Enrollment
64
Registered
2017-02-28
Start date
2010-11-30
Completion date
2020-07-23
Last updated
2020-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia, Esophageal, Esophageal Cancer

Keywords

Cancer of the gastro-esophageal junction, Watson score, Ogilvie score, Goldschmid score, Validation, Quality of Life

Brief summary

This study validates 3 well known dysphagia scores for dysphagia due to malignancies of the oesophagus and gastro-oesophageal junction and to the Swedish language.

Detailed description

In the present study, our aim was to firstly, validate 3 commonly used scales for use in patients with dysphagia due to malignancy, and secondly, to validate them in the Swedish language. The 3 scales were: The Watson dysphagia scale, which was developed in studies on surgical treatment of reflux disease. It consists of questions about food with 9 different viscosity and solidity and the patient answer if they have problems with a specific food: never, sometimes or always when ingesting this. The scores are added and provides a range of 0-45 where 45 is the worst possible dysphagia. The Ogilvie score is a 5-graded scale 0-4 where 4 is total inability to swallow. The Goldschmid score is graded from 0-5 where 0 is inability to swallow and 5 is normal function. QoL was measured with validated instruments originating from the European Organization for Research and Treatment of Cancer (EORTC), which has a generic instrument that measures global QoL in patients with cancer (QLQ-C30) and a more symptom-specific instrument that is developed for cancer in the oesophagus and stomach (QLQ-OG25). These are well known, validated instruments that also have normal reference values for the healthy population. The symptom specific instrument QLQ-OG25 includes a dysphagia module consisting of 3 questions which is validated to malignant disease and food intake with the help of expert groups and deep interviews with patients.

Interventions

OTHERValidation of different dysphagia scores

Sponsors

Sahlgrenska University Hospital
CollaboratorOTHER
The Göteborg Medical Society, Sweden
CollaboratorUNKNOWN
Vastra Gotaland Region
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Cancer in the gastro-esophageal junction or in the esophagus * Dysphagia * Ability to fill in the questionnaires * Written acceptance of the informed consent

Exclusion criteria

* Not for-filling inclusion criteria * No consent

Design outcomes

Primary

MeasureTime frame
Validation of dysphagia scores10-14 days
Translation of scores to the Swedish language10-14 days

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026